Put Options

17 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q2 2022

Aug 16, 2022

SELL
$11.23 - $19.59 $622,142 - $1.09 Million
-55,400 Closed
0 $0
Q1 2022

May 17, 2022

BUY
$13.37 - $17.79 $268,737 - $357,579
20,100 Added 56.94%
55,400 $901,000
Q4 2021

Feb 15, 2022

SELL
$14.28 - $19.53 $465,528 - $636,678
-32,600 Reduced 48.01%
35,300 $575,000
Q3 2021

Nov 16, 2021

SELL
$12.99 - $20.47 $1.47 Million - $2.32 Million
-113,200 Reduced 62.51%
67,900 $1.01 Million
Q2 2021

Aug 16, 2021

BUY
$15.46 - $24.5 $1.67 Million - $2.64 Million
107,700 Added 146.73%
181,100 $3.62 Million
Q1 2021

May 18, 2021

SELL
$19.33 - $37.75 $1.11 Million - $2.17 Million
-57,600 Reduced 43.97%
73,400 $1.69 Million
Q4 2020

Feb 17, 2021

BUY
$24.48 - $42.47 $1.45 Million - $2.52 Million
59,300 Added 82.71%
131,000 $3.24 Million
Q3 2020

Nov 17, 2020

SELL
$39.09 - $53.44 $539,442 - $737,472
-13,800 Reduced 16.14%
71,700 $2.97 Million
Q2 2020

Aug 17, 2020

BUY
$46.7 - $92.04 $3.18 Million - $6.27 Million
68,100 Added 391.38%
85,500 $4.1 Million
Q1 2020

May 15, 2020

SELL
$48.35 - $118.68 $468,995 - $1.15 Million
-9,700 Reduced 35.79%
17,400 $1.1 Million
Q4 2019

Feb 14, 2020

BUY
$57.36 - $124.1 $963,648 - $2.08 Million
16,800 Added 163.11%
27,100 $3.36 Million
Q2 2019

Aug 15, 2019

SELL
$77.77 - $120.68 $567,721 - $880,964
-7,300 Reduced 41.48%
10,300 $820,000
Q1 2019

May 16, 2019

BUY
$91.83 - $120.68 $1.32 Million - $1.74 Million
14,400 Added 450.0%
17,600 $1.97 Million
Q2 2018

Aug 15, 2018

SELL
$60.0 - $85.67 $288,000 - $411,216
-4,800 Reduced 60.0%
3,200 $269,000
Q1 2018

May 15, 2018

SELL
$52.72 - $67.25 $247,784 - $316,075
-4,700 Reduced 37.01%
8,000 $492,000
Q4 2017

Feb 15, 2018

SELL
$58.2 - $72.76 $349,200 - $436,560
-6,000 Reduced 32.09%
12,700 $742,000
Q3 2017

Nov 14, 2017

BUY
$57.01 - $118.75 $1.07 Million - $2.22 Million
18,700
18,700 $1.09 Million

Others Institutions Holding ICPT

About INTERCEPT PHARMACEUTICALS, INC.


  • Ticker ICPT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 41,127,400
  • Description
  • Intercept Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics to treat progressive non-viral liver diseases in the United States, Europe, and Canada. The company markets Ocaliva, a farnesoid X receptor agonist used for the treatment of primary biliary cholangitis in combination wit...
More about ICPT
Track This Portfolio

Track Jane Street Group, LLC Portfolio

Follow Jane Street Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jane Street Group, LLC with notifications on news.